Consumer Health Immunology

Hummingbird Bioscience to Present Pre-Clinical Data on Novel Biomarkers for HER3-driven Cancers

Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets, today announce...

 October 08, 2021 | News

Japan to Encourages Breakthrough Cancer Research

Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company, today announced the two winners of the 17th annual JCA Mauvernay Awar...

 October 05, 2021 | News

GenScript ProBio and AskGene Enter into a Non-exclusive License of A sdAb Targeting Immune Checkpoint Target

GenScript ProBio grants a non-exclusive global license to AskGene to use GenScript ProBio's sdAb targeting immune checkpoint target for disc...

 September 27, 2021 | News

Australia Approved New Therapy to Treat Advanced Small Cell Lung Cancer

Highlights: ZEPZELCA® (lurbinectedin) is the first new therapy approved to treat second-line metastatic SCLC in Australia in more tha...

 September 15, 2021 | News

Taiwan to provide smart access to personalized cancer care

Varian, a Siemens Healthineers company, announced today that China Medical University Hospital in Central Taiwan treated its first patient with E...

 September 13, 2021 | News

Elekta to address Indonesia's cancer care gap with direct presence

Elekta (EKTA-B.ST) announced today that is has established permanent legal entity in Indonesia's capital, Jakarta in order to address t...

 August 25, 2021 | News

InnoCare Announces First Subject Dosed in Clinical Trial of ICP-332

InnoCare discovered and developed the oral drug candidate ICP-332. As a non-receptor tyrosine kinase, TYK2 is a member of the JAK kinase family, which is a...

 August 16, 2021 | News

Terumo Blood and Cell Technologies and PhotonPharma Inc. announce collaboration to develop a novel cancer immunotherapy

 Terumo Blood and Cell Technologies (Terumo), a medical device company specializing in a portfolio of technology, software and services for blood...

 August 12, 2021 | News

VERAXA Biotech and Indivumed Cooperate on the Development of Precision Oncology Antibody

The targets have been identified by Indivumed’s discovery solution platform nRavel®, only two months after its launch. The antibody development a...

 August 10, 2021 | News

Pharmaxis Cancer Drug Decreases Tumour Burden in Pre Clinical Liver Cancer Model

Clinical stage drug development company Pharmaxis Ltd (ASX: PXS) today announced the first public presentation of data from a preclinical study of PXS-5505...

 August 06, 2021 | News

Zelgen and 111, Inc. to Develop a New Management Platform for Liver Cancer Patients in China

 111, Inc. , a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in&nb...

 August 04, 2021 | News

eTheRNA immunotherapies opens office in Hong Kong to support and build on its growing activities in China and broader Asia-Pacific

The Asia-Pacific region is growing in importance in the global healthcare sector and this new subsidiary will serve as a focus for eTheRNA’s increasi...

 August 03, 2021 | News

Clarity commences theranostic prostate cancer trial

Clarity's Executive Chairman, Dr Alan Taylor, commented, "The prostate cancer market is a key focus for Clarity and we are very pleased to commence th...

 July 29, 2021 | News

Zhongchao To Promote the Equalization of Breast Cancer Diagnosis

Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering patient management, online healthcare information, pro...

 July 28, 2021 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close